InvestorsHub Logo
Followers 70
Posts 3219
Boards Moderated 0
Alias Born 07/11/2011

Re: None

Saturday, 09/19/2015 12:52:44 AM

Saturday, September 19, 2015 12:52:44 AM

Post# of 32016
IMO, Sanofi needs to get the CLAMP study/others done before moving into high gear with Afrezza.

Think about hammering home the points "Inhalable Insulin that is #1 ultra-rapid acting." The demo's & testimonials online of Afrezza clearly show the superior treatment for T1 & T2's to lead a normal life on the go, with a discreet & fast solution.

And, Technosphere technology will blossom to help with other ailments beyond diabetes. MNKD is a total hidden gem.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MNKD News